Skip to Content
🌐Ship toSelect country

Stylage Bi-Soft S Lidocaine - 2 x 0,8ml

Stylage Bi-Soft S Lidocaine is the lidocaine-containing version of Stylage Bi-Soft S, sharing the same fine-line correction profile (crow's feet, forehead lines, lip contour, perioral lines, tear trough) via cross-linked HA plus mannitol, with lidocaine added for improved treatment comfort. Intended for intradermal-to-mid-dermal injection and low-level volume correction only. For use by licensed, trained medical professionals only.

94.00 € 94.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand STYLAGE®
SKU A5207 Share
Treatment Areas Crow's FeetForeheadGlabella FoldsPerioral foldsTear Troughs
Tags Cross-Linked Hyaluronic AcidFine LinesLidocaine

Stylage Bi-Soft S Lidocaine is the lidocaine-enhanced version of Stylage Bi-Soft S, combining a lighter cross-linked hyaluronic acid formulation (IPN-Like technology with mannitol) with lidocaine, for fine to moderate superficial lines with a more comfortable injection experience.

CONCENTRATION

  • Cross-linked hyaluronic acid (IPN-Like technology, lighter formulation) + mannitol
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 2 x 0.8ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 4-6 months, depending on individual metabolism.

INDICATIONS

  • Fine to moderate superficial lines
  • Delicate facial areas

TREATMENT AREAS

  • Crow's feet
  • Perioral folds
  • Face, general

Stylage Bi-Soft S Lidocaine is injected into the superficial to mid dermis using fine linear threading technique.

Results are visible immediately, with final results assessed after 1-2 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin